Search

everythinglearnresearchcommunity

for

Search:↓

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

Minoxidil helps hair growth but has side effects.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

PRP is promising for skin, hair, and wound treatments but needs standardized methods and more research.

Trichoscopy is crucial for diagnosing and managing androgenetic alopecia, showing increased vellus hairs, empty follicles, and fibrosis with severity.

Hair loss significantly affects quality of life, especially for women, in Pakistan.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

The new visual scale is a quick and effective way to measure hair loss in women.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

The document suggests using a topical Vitamin D treatment for hair loss rather than oral supplements and calls for more research.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Dr. Rodney Sinclair uses a detailed grading system to diagnose female pattern hair loss, recommends daily spironolactone and minoxidil for treatment, and believes genetics play a role in the condition.